Form 8-K - Current report:
SEC Accession No. 0001493152-25-003914
Filing Date
2025-01-28
Accepted
2025-01-28 08:00:21
Documents
17
Period of Report
2025-01-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42093
2 ex10-1.htm EX-10.1 242395
3 ex10-2.htm EX-10.2 114590
4 ex99-1.htm EX-99.1 9089
5 ex99-1.jpg GRAPHIC 22290
  Complete submission text file 0001493152-25-003914.txt   688179

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE orgs-20250128.xsd EX-101.SCH 3018
7 XBRL LABEL FILE orgs-20250128_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE orgs-20250128_pre.xml EX-101.PRE 24167
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3427
Mailing Address 20271 GOLDENROD LANE GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE GERMANTOWN MD 20876 (480) 659-6404
Orgenesis Inc. (Filer) CIK: 0001460602 (see all company filings)

EIN.: 980583166 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38416 | Film No.: 25560985
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)